BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 28502145)

  • 1. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
    Ea R; Aa G; Ag ES; Ma A
    Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.
    Firdaus R; Biswas A; Saha K; Mukherjee A; Chaudhuri S; Chandra A; Konar A; Sadhukhan PC
    PLoS One; 2014; 9(6):e99126. PubMed ID: 24914551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
    Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
    World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.
    Riva E; Scagnolari C; Monteleone K; Selvaggi C; Picardi A; Mazzarelli C; Pizzigallo E; Vincenzi B; Carducci A; Antonaci S; Giannelli G; Antonelli G
    J Viral Hepat; 2012 Sep; 19(9):650-3. PubMed ID: 22863269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.
    Shaker O; Rashad A; Abd El Aziz G; El Raziky M
    Cell Biochem Biophys; 2015 Jan; 71(1):307-14. PubMed ID: 25115611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
    Halfon P; Bourliere M; Ouzan D; Maor Y; Renou C; Wartelle C; Pénaranda G; Tran A; Botta D; Oules V; Castellani P; Portal I; Argiro L; Dessein A
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):931-5. PubMed ID: 21900787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.
    Fischer J; Böhm S; Scholz M; Müller T; Witt H; George J; Sarrazin C; Susser S; Schott E; Suppiah V; Booth DR; Stewart GJ; van Bömmel F; Brodzinski A; Fülöp B; Migaud P; Berg T
    Hepatology; 2012 Jun; 55(6):1700-10. PubMed ID: 22234924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.
    Fathy MM; Abo Taleb ME; El Hawary MS; Nabih MI; Aref WM; Makhlouf MM
    Cytokine; 2015 Aug; 74(2):268-72. PubMed ID: 26003758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.
    Palenzuela Gardón D; Guillen IA; Fernández JR; Camacho H; Estevez ZC; Dueñas S; Alvares-Lajonchere L; Amador Y; Martinez-Donato G; Han J; Zhang Z; Zhang X; Gao Y; Campaña JR; Novoa LI
    J Biomol Tech; 2017 Jul; 28(2):80-86. PubMed ID: 28058039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
    Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
    Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
    Moghaddam A; Melum E; Reinton N; Ring-Larsen H; Verbaan H; Bjøro K; Dalgard O
    Hepatology; 2011 Mar; 53(3):746-54. PubMed ID: 21374656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.
    Sticchi L; Di Biagio A; Rappazzo E; Setti M; De Rosa G; De Hoffer L; Nicolini L; Prinapori R; Bruzzone B
    J Prev Med Hyg; 2013 Jun; 54(2):83-6. PubMed ID: 24396987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
    Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
    J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
    Kobayashi M; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Chayama K; Miyakawa Y; Kumada H
    J Gastroenterol; 2012 May; 47(5):596-605. PubMed ID: 22438096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon λ3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Biswas A; Firdaus R; Gupta D; Ghosh M; Saha K; Chowdhury P; Bhattacharyya M; Sadhukhan PC
    Transfusion; 2017 Jun; 57(6):1376-1384. PubMed ID: 28419488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.